Capital Analysts LLC’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61K | Hold |
932
| – | – | ﹤0.01% | 772 |
|
|
2025
Q1 | $66K | Sell |
932
-643
| -41% | -$45.5K | ﹤0.01% | 735 |
|
|
2024
Q4 | $104K | Buy |
1,575
+464
| +42% | +$30.6K | ﹤0.01% | 603 |
|
|
2024
Q3 | $78K | Hold |
1,111
| – | – | ﹤0.01% | 632 |
|
|
2024
Q2 | $74K | Buy |
1,111
+286
| +35% | +$19.1K | ﹤0.01% | 634 |
|
|
2024
Q1 | $56K | Sell |
825
-2,382
| -74% | -$162K | ﹤0.01% | 642 |
|
|
2023
Q4 | $198K | Buy |
+3,207
| New | +$198K | 0.01% | 426 |
|
|
2018
Q1 | – | Sell |
-390
| Closed | -$20K | – | 565 |
|
|
2017
Q4 | $20K | Buy |
+390
| New | +$20K | ﹤0.01% | 362 |
|